BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 38749911)

  • 1. Screening for hepatitis C virus at the time of mammography using rapid diagnostic tests in women aged between 50 and 74 years (Mamm'OC NCT05067374).
    Meszaros M; Coursier S; Nagot N; Moulis L; Taourel P; Pages-Bouic E; Fabre-Demard N; Trentini M; Pageaux GP; Donnadieu H
    J Viral Hepat; 2024 May; ():. PubMed ID: 38749911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
    Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
    Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling.
    Parry JV; Easterbrook P; Sands AR
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):705. PubMed ID: 29143611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
    Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
    J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-testing for HIV, HBV, and HCV using finger-stick whole-blood multiplex immunochromatographic rapid test: A pilot feasibility study in sub-Saharan Africa.
    Tonen-Wolyec S; Djang'eing'a RM; Batina-Agasa S; Kayembe Tshilumba C; Muwonga Masidi J; Hayette MP; Bélec L
    PLoS One; 2021; 16(4):e0249701. PubMed ID: 33836036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing Molecular Point-of-Care Testing and Dried Blood Spot for Hepatitis C Virus Screening in People Who Inject Drugs.
    Chevaliez S; Wlassow M; Volant J; Roudot-Thoraval F; Bachelard A; Poiteau L; Trabut JB; Hézode C; Bourdel A; Dominguez S
    Open Forum Infect Dis; 2020 Jun; 7(6):ofaa196. PubMed ID: 32617372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C screening in Lithuania: first-year results and scenarios for achieving WHO elimination targets.
    Petkevičienė J; Voeller A; Čiupkevičienė E; Razavi-Shearer D; Liakina V; Jančorienė L; Kazėnaitė E; Zaksas V; Urbonas G; Kupčinskas L
    BMC Public Health; 2024 Apr; 24(1):1055. PubMed ID: 38622549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical performances of simultaneous detection of HIV-1, HIV-2 and hepatitis C- specific antibodies and hepatitis B surface antigen (HBsAg) by multiplex immunochromatographic rapid test with serum samples: A cross-sectional study.
    Robin L; Mboumba Bouassa RS; Nodjikouambaye ZA; Charmant L; Matta M; Simon S; Filali M; Mboup S; Bélec L
    J Virol Methods; 2018 Mar; 253():1-4. PubMed ID: 29208530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis C infection, screening and associated factors among men who have sex with men attending gay venues: a cross-sectional survey (PREVAGAY), France, 2015.
    Vaux S; Chevaliez S; Saboni L; Sauvage C; Sommen C; Barin F; Alexandre A; Jauffret-Roustide M; Lot F; Velter A;
    BMC Infect Dis; 2019 Apr; 19(1):315. PubMed ID: 30971207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver health events: an indigenous community-led model to enhance HCV screening and linkage to care.
    Pandey M; Konrad S; Reed N; Ahenakew V; Isbister P; Isbister T; Gallagher L; Campbell T; Skinner S
    Health Promot Int; 2022 Feb; 37(1):. PubMed ID: 34125199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergency department targeted screening for hepatitis C does not improve linkage to care.
    Houri I; Horowitz N; Katchman H; Weksler Y; Miller O; Deutsch L; Shibolet O
    World J Gastroenterol; 2020 Aug; 26(32):4878-4888. PubMed ID: 32921964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting.
    Sharafi H; Poustchi H; Azimian F; Tamadoni B; Ramezani R; Gouya MM; Sheikh M; Hashemi F; Tashakorian M; Alasvand R; Alavian SM; Merat S
    J Clin Virol; 2019 Apr; 113():20-23. PubMed ID: 30825832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of HIV, Hepatitis C and Hepatitis B Infection Among Detainees in a French Administrative Detention Centre.
    Mancy S; Fabbro-Peray P; Alonso S; Berkaoui H; Lambremon L; Vidal H; Hilaire C; Herrmann D; Dapoigny J; Kinné M
    J Epidemiol Glob Health; 2024 May; ():. PubMed ID: 38739355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying cost-effective screening algorithms for active hepatitis C virus infections in a high prevalence setting.
    Jülicher P; Galli C
    J Med Econ; 2018 Jan; 21(1):1-10. PubMed ID: 28881157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HepFREEPak: protocol for a multi-centre, prospective observational study examining efficacy and impact of current therapies for the treatment of hepatitis C in Pakistan and reporting resistance to antiviral drugs: study protocol.
    Arif A; Hasnain A; Chaudhry A; Asim M; Shafqat MN; Altaf A; Saba N; Kemos P; Ansari MA; Barnes E; Metcalfe C; Vickerman P; Qureshi H; Hamid S; Choudhry AA; Niaz SK; Foster GR; Choudhry N
    BMC Public Health; 2023 Dec; 23(1):2529. PubMed ID: 38110885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of positive rapid diagnostic test of hepatitis C virus infection in Ghana.
    Birjandi MM; Oroei M
    Pan Afr Med J; 2020; 36():322. PubMed ID: 33193976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating Routine HCV Testing in Primary Care: Lessons Learned from Five Federally Qualified Health Centers in Philadelphia, Pennsylvania, 2012-2014.
    Coyle C; Kwakwa H; Viner K
    Public Health Rep; 2016; 131 Suppl 2(Suppl 2):65-73. PubMed ID: 27168664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in inpatient and outpatient hepatitis C virus prevalence and linkage to care rates in a safety net hospital hepatitis C screening program.
    Veeramachaneni H; Park B; Blakely D; Palacio A; Darby R; Fluker SA; Lyles RH; Miller LS
    J Gastroenterol Hepatol; 2021 Aug; 36(8):2285-2291. PubMed ID: 33724551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-Routine HCV/HIV Testing: Seroprevalence and Linkage to Care in Four Community Health Centers in Philadelphia, Pennsylvania.
    Coyle C; Kwakwa H
    Public Health Rep; 2016; 131 Suppl 1(Suppl 1):41-52. PubMed ID: 26862229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C Virus Prevalence and Risk Factors in a Village in Northeastern Romania-A Population-Based Screening-The First Step to Viral Micro-Elimination.
    Huiban L; Stanciu C; Muzica CM; Cuciureanu T; Chiriac S; Zenovia S; Burduloi VM; Petrea O; Sîngeap AM; Gîrleanu I; Sfarti C; Cojocariu C; Trifan A
    Healthcare (Basel); 2021 May; 9(6):. PubMed ID: 34072635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.